Interpretation of idarucizumab clinical trial data based on spontaneous reports of dabigatran adverse effects in the French pharmacovigilance database - Université de Bretagne Occidentale
Article Dans Une Revue Thrombosis Research Année : 2016

Interpretation of idarucizumab clinical trial data based on spontaneous reports of dabigatran adverse effects in the French pharmacovigilance database

Fichier non déposé

Dates et versions

hal-02044161 , version 1 (21-02-2019)

Identifiants

  • HAL Id : hal-02044161 , version 1

Citer

Albert Trinh-Duc, Agnès Lillo-Le Louët, Éric Tellier, Thibault Viard, Grégoire Le Gal, et al.. Interpretation of idarucizumab clinical trial data based on spontaneous reports of dabigatran adverse effects in the French pharmacovigilance database. Thrombosis Research, 2016, 146 (9), pp.43-45. ⟨hal-02044161⟩
27 Consultations
0 Téléchargements

Partager

More